Veliparib plus temozolomide in metastatic melanoma trends toward increased PFS but results are not statistically significant
Oncology 25(12): 1213 1232
2011
ISSN/ISBN: 0890-9091 PMID: 22229218 Document Number: 653835
Document emailed within 1 workday
Related Documents
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285Hill, C. 1991: When is a difference statistically significant? Journal de Radiologie 72(2): 129-131
Markham, J. 1985: Statistically significant or significant? Canadian Medical Association Journal 132(8): 902
Tiilikainen, A. 1980: Is there biological relevance in the statistically significant association between the HLA system and disease? Medical Biology 58(5): 241-245
Schauenburg, H.; Strack, M. 1998: The Symptom Checklist-90-R (SCL-90-R) for presenting statistically and clinically significant psychotherapy outcome Psychotherapie Psychosomatik Medizinische Psychologie 48(7): 257-264
2015: (P128) Statistically Significant Calibration Curve for Ir-192 HDR Source Using Multichannel Gafchromic Film Analysis Oncology 29(4 Suppl. 1)
Salk, D. 1988: Technetium-labeled monoclonal antibodies for imaging metastatic melanoma: results of a multicenter clinical study Seminars in Oncology 15(6): 608-618
Seegenschmiedt, M.H. 1996: Randomized multicenter ESHO-study: Hyperthermia improves results in recurrent and metastatic malignant melanoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 172(5): 276-278
Legha, S.S.; Ring, S.; Eton, O.; Bedikian, A.; Plager, C.; Papadopoulos, N. 1997: Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience Cancer Journal from Scientific American 3 Suppl. 1: S9-15
Dutcher, J.P. 2011: High-dose interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma: still the standard Oncology 25(5): 427-428
Saha, S.; Mohanty, K.C. 2003: Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung Indian Journal of Experimental Biology 41(11): 1253-1258
Frydland, M.; Elming, H.; Ahlehoff, O. 2014: Malignant melanoma with metastatic melanoma to the heart Ugeskrift for Laeger 176(25)
Skowronek, J.; Roszak, A. 1997: A case of metastatic malignant melanoma of the vagina with a background of primary vaginal melanoma--clinical case Ginekologia Polska 68(8): 390-393
van Groningen, J.J.; Bloemers, H.P.; Swart, G.W. 1995: Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display Cancer Research 55(24): 6237-6243
2006: Data trends. ICU stays having a significant impact on hospital margins Healthcare financial management: journal of the Healthcare Financial Management Association 60(7): 114
Ly, B.H.; Vlastos, G.; Rapiti, E.; Vinh-Hung, V.; Nguyen, N.P. 2010: Local-regional radiotherapy and surgery is associated with a significant survival advantage in metastatic breast cancer patients Tumori 96(6): 947-954
Chouake, J.; Friedman, A. 2012: Novel therapies for the treatment of metastatic melanoma Journal of Drugs in Dermatology: Jdd 11(2): 271-273
Nicolae, C.D.; Nicolae, I. 2013: Antibodies against GM1 gangliosides associated with metastatic melanoma Acta Dermatovenerologica Croatica: Adc 21(2): 86-92
Mojiminiyi, O.A.; Stretch, J.R.; Shepstone, B.J.; Soper, N.D.; Godfrey, A.M.; Poole, M.D. 1991: Preclinical detection of metastatic melanoma Journal of Nuclear Biology and Medicine 35(2): 73-75
Carboni, F.; Graziano, F.; Lonardo, M.T.; Lepiane, P.; Santoro, R.; Lorusso, R.; Mancini, P.; Santoro, E. 2004: Pancreaticoduodenectomy for pancreatic metastatic melanoma Journal of Experimental and Clinical Cancer Research: Cr 23(3): 539-543